We are excited to announce that we are expanding the scope and reach of our BHI training programs with new courses for physicians and nurse practitioners. Upcoming courses will combine CME approved courses through our affiliation with SUNY-Downstate College of Medicine as well as non-CME educational courses, webinars and ongoing monthly clinical training programs. Topics addressed will include:
DIET DRUG: Channel 13's Erin Kiernan investigates what is really in the HCG supplements that claim you'll drop weight fast.
Products making lots of promises are everywhere from the grocery store to the pharmacy. From re-growing cartilage to protecting your heart, it seems like you might be able to fix just about anything that ails you! But the most enticing claims are those related to weight loss.
For many years doctors believed the estrogen women consumed in the form of oral contraceptives and hormone replacement therapy (HRT) pills was good for their patients’ hearts. Recent studies however have shown that long-term exposure to estrogen can be a danger to women as it has been associated with high blood pressure, a key link to heart- and brain-attacks (strokes).
A new study presented at the 65th Vascular Annual Meeting of the Society of Vascular Surgery found the use of HRT in postmenopausal women is associated with a significant reduction in the prevalence of peripheral arterial disease. The authors studied data from 847,982 postmenopausal women. The researchers found that women who used HRT were found to have a 20% decreased risk of developing arteral disease. In addition there was a similar decline in diabetes in HRT users as compared to non-HRT users.
Finally there is good news to the six to ten million American women who have to receive hormone replacement therapy (HTR) against cancer. Parsley and celery, two typical well known ingredients of many delicious dishes, are able to stop certain breast cancer tumor cells from growing and multiplying. That’s at least the preliminary conclusion of a study led by researchers of the University of Missouri.
Pfizer, the world’s largest drug maker, has reportedly agreed to settle one-third of the approximately 10,000 pending cases in which plaintiffs’ have alleged that Pfizer failed to properly warn of the risk of taking Prempro, a hormone replacement therapy (HRT) drug that was prescribed to women to treat symptoms of menopause.
A recent European study found that women who use birth control pills are more likely to experience sexual dysfunction such as reduced desire and arousal than women who use other non-hormonal contraception and women who do not use contraception.